Actively Recruiting
Evaluation of the VDyne Transcatheter Tricuspid Valve Replacement System for Treating Tricuspid Regurgitation Safety and Efficacy Clinical Study
Led by VDyne, Inc. · Updated on 2026-08-13
120
Participants Needed
21
Research Sites
208 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to collect safety and effectiveness data for the VDyne Transcatheter Tricuspid Valve Replacement System as a treatment for tricuspid regurgitation. The study supports obtaining the Conformit Europenne CE Mark for this device. It focuses on adults with severe tricuspid valve regurgitation and evaluates the devices impact on heart valve function and patient health. Participants will receive treatment using the VDyne System during the study. This investigational device is designed to replace the tricuspid valve via a catheter-based procedure. The study follows a single group receiving the VDyne System, with assessments occurring from baseline through up to one year after the procedure to monitor safety and treatment effects. Throughout the trial, participants will be monitored for major adverse events related to the device or procedure, changes in valve leakage, symptom status, functional ability measured by a six-minute walk test, and quality of life. Evaluations include imaging reviews and clinical assessments at 1 month, 3 months, 6 months, and 1 year post-procedure. The total study duration spans several years, with primary safety outcomes assessed within 30 days and longer-term follow-up extending to one year after treatment.
CONDITIONS
Brief Title
Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation
Research Team
V
Vinny Podichetty
P
Pree Bassi
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here